Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
for oclacitinib, the target cytokines are those that are proinflammatory or have a role in allergic responses/pruritis.
oklatsitiniib mõjutab proinflammatoorseid ja allergilistes reaktsioonides / kiheluses osalevaid tsütokiine.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 2
Qualità:
as a result, secukinumab inhibits the release of proinflammatory cytokines, chemokines and mediators of tissue damage and reduces il-17a-mediated contributions to autoimmune and inflammatory diseases.
selle tulemusena inhibeerib sekukinumab proinflammatoorsete tsütokiinide, kemokiinide ja koekahjustuse mediaatorite vabanemist ning vähendab il-17a vahendatud toimeid autoimmuunsete ja põletikuliste haiguste puhul.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
these include inhibiting the release of proinflammatory cytokines such as il-4, il-6, il-8, and il-13 from human mast cells/basophils, as well as inhibition of the expression of the adhesion molecule p-selectin on endothelial cells.
desloratadiin pärsib põletikule eelnevate tsütokiinide il-4, il-6, il-8 ja il-13 vabanemist inimese nuumrakkudest/basofiilidest ning pärsib adhesioonimolekul p-selektiini ekspressiooni endoteeli rakkudes.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 3
Qualità:
